STT:NYSEState Street Corporation Analysis
Data as of 2026-03-10 - not real-time
$121.93
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
State Street Corp (STT) is trading at $121.93, well below its DCF fair value of $883 and an 18% upside potential, while its P/E of ~13 is comfortably under the industry average of 17.4, indicating a sizable valuation gap. Technical signals are mixed: the price sits beneath the 20‑day SMA (128.04) and 50‑day SMA (129.67), the RSI is at 39 suggesting modest oversold pressure, and a bearish MACD histogram reinforces short‑term downside bias. However, the 200‑day SMA (116.51) is below the current price, hinting that the longer‑term trend remains intact. Fundamentally, STT delivers solid earnings with a trailing EPS of $9.40, operating margin of 34%, and revenue growth of 7.6% YoY, supported by a massive cash pile of $143 B versus $55.9 B of debt, resulting in a zero‑debt‑to‑equity ratio. The dividend yield of 2.76% and a modest 34% payout ratio underscore dividend sustainability, while a beta around 1.1‑1.4 and 30% 30‑day volatility signal heightened market sensitivity. Recent material news highlights a new quarterly dividend declaration and a strategic partnership with Neudata to expand data services, reinforcing the company’s focus on growth and client‑centric innovation. Overall, the stock presents a compelling blend of value and growth attributes, with upside potential tempered by short‑term technical weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below 20‑day and 50‑day SMAs
- Bearish MACD histogram
- RSI indicating near‑oversold condition
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to DCF and peers
- Strong cash position and low debt
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Durable asset‑management franchise
- Consistent revenue growth and operating margins
- Strategic data partnership expanding service offerings
Key Metrics & Analysis
Financial Health
Revenue Growth7.60%
Profit Margin21.21%
P/E Ratio13.0
ROE11.08%
ROA0.82%
P/B Ratio1.4
Op. Cash Flow$11.9B
Industry P/E17.4
Technical Analysis
TrendNeutral
RSI39.0
Support$116.15
Resistance$135.36
MA 20$128.04
MA 50$129.67
MA 200$116.51
MACDBearish
VolumeIncreasing
Fear & Greed Index77.07
Valuation
Fair Value$883.27
Target Price$144.30
Upside/Downside18.35%
GradeUndervalued
TypeBlend
Dividend Yield2.76%
Risk Assessment
Beta1.14
Volatility30.28%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.